The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma.
 
Jian Li Campian
Consulting or Advisory Role - Alexion Pharmaceuticals; Arbor Pharmaceuticals; Dova Pharmaceuticals; Incyte; Inovio Pharmaceuticals
Speakers' Bureau - Abbvie (I)
Research Funding - NeoImmuneTech
Travel, Accommodations, Expenses - NantWorks
 
Christopher Abraham
No Relationships to Disclose
 
Jingqin Luo
No Relationships to Disclose
 
Grayson Talcott
No Relationships to Disclose
 
Ruth Katumba
No Relationships to Disclose
 
Albert H Kim
No Relationships to Disclose
 
Gavin P. Dunn
Leadership - ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Immunovalent Therapeutics
 
George Ansstas
Consulting or Advisory Role - Novartis
Research Funding - Novocure
 
Tanner Michael Johanns
Consulting or Advisory Role - Geneos; Novocure
 
Matthew A Ciorba
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Takeda
Research Funding - Incyte (Inst)
 
Milan G Chheda
Patents, Royalties, Other Intellectual Property - Zika virus patent; Zika virus patent (Inst)
 
Jiayi Huang
Research Funding - Cantex Pharmaceuticals; Pfizer/EMD Serono